🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
AION is the main cause of blindness in patients with GCA. High dose steroid...
Status
Unknown
Location
CHU de Caen - Hôpital de la Côte de Nacre
Start Date
2020-09-10
Trial ID
NCT04239196
Treatments Being Tested
This study is about TAK-500, given either alone or with pembrolizumab, in a...
Status
Terminated
Location
Univeristy of Alabama at Birmingham
Start Date
2022-04-14
Trial ID
NCT05070247
Treatments Being Tested
In patients with COVID-19, severe hypoxemic respiratory failure (SRF) leadi...
Status
Unknown
Location
University Hospital of Alexandroupolis
Start Date
2020-10-25
Trial ID
NCT05279391
This Phase II, open-label, multicenter study will evaluate the safety, effi...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2022-03-22
Trial ID
NCT04980222
Treatments Being Tested
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform tria...
Status
Recruiting
Location
University of Florida
Start Date
2016-04-11
Trial ID
NCT02735707
Treatments Being Tested
This study aimed to compare the efficacy and safety of a precision treatmen...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2024-06-28
Trial ID
NCT06498089
Treatments Being Tested
This study will evaluate the safety, pharmacokinetics, and preliminary effi...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2019-03-08
Trial ID
NCT03677141
This is an umbrella study evaluating the efficacy and safety of multiple tr...
Status
Recruiting
Location
City of Hope
Start Date
2018-03-30
Trial ID
NCT03424005
Treatments Being Tested
This is a phase 1B, multi-center, dose-finding study of glofitamab administ...
Status
Completed
Location
University of Alabama Medical Center
Start Date
2018-03-13
Trial ID
NCT03467373